Avricore Health Inc. (AVCRF)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.48 Million | 1.76 Million | 122.8 Thousand | 33.03 Thousand | 33 Thousand | 226.44 Thousand |
| Cost of Revenue | 2.28 Million | 1.31 Million | 92.28 Thousand | 15.55 Thousand | 18.5 Thousand | 188.39 Thousand |
| Gross Profit | 1.2 Million | 456.79 Thousand | 30.52 Thousand | 17.48 Thousand | 14.49 Thousand | 38.05 Thousand |
| Operating Expenses | 1.2 Million | 1.26 Million | 1.76 Million | 870.72 Thousand | 1.61 Million | 2.91 Million |
| Selling, General and Administrative Expenses | 1.84 Million | 1.18 Million | 1.7 Million | 847.91 Thousand | 1.34 Million | 1.99 Million |
| Research and Development Expenses | - | - | - | - | - | 251.5 Thousand |
| Other Expenses | - | 87.68 Thousand | 63.1 Thousand | 22.8 Thousand | 265.6 Thousand | 667.63 Thousand |
| Cost and Expenses | 4.06 Million | 2.58 Million | 1.86 Million | 886.27 Thousand | 1.63 Million | 3.1 Million |
| Operating Income | -583.26 Thousand | -809.85 Thousand | -1.74 Million | -859.15 Thousand | -1.6 Million | -2.88 Million |
| Interest Expense | - | 8369.00 | 38.43 Thousand | 158.95 Thousand | 5144.00 | 102.00 |
| Income Tax Expense | - | 8369.00 | 38.43 Thousand | 158.95 Thousand | 196.59 Thousand | 1.25 Million |
| Earnings before Tax | -701.21 Thousand | -818.22 Thousand | -1.7 Million | -1.17 Million | -1.91 Million | -4.13 Million |
| Net Income | -701.21 Thousand | -826.59 Thousand | -1.74 Million | -1.33 Million | -2.11 Million | -5.39 Million |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.02 | -0.02 | -0.04 | -0.16 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.02 | -0.02 | -0.04 | -0.16 |
| Weighted Average Shares Outstanding | 99.55 Million | 97.85 Million | 92.61 Million | 60.44 Million | 47.29 Million | 33.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 99.55 Million | 97.85 Million | 92.61 Million | 60.44 Million | 47.29 Million | 33.86 Million |
| Gross Margin | 0.35 | 0.26 | 0.25 | 0.53 | 0.44 | 0.17 |
| EBIT Margin | -0.08 | -0.35 | -14.06 | -26.01 | -43.03 | -10.36 |
| Profit Margin | -0.20 | -0.47 | -14.22 | -40.35 | -64.03 | -23.81 |
| EBITDA | -281.14 Thousand | -635.18 Thousand | -1.65 Million | -930.39 Thousand | -1.42 Million | -2.34 Million |
| Earnings Before Tax Margin | -0.17 | -0.46 | -14.21 | -26.01 | -48.50 | -12.73 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.04 Million | 1.12 Million | 1.35 Million | 3.48 Million | 953.45 Thousand | 548.04 Thousand |
| Cost of Revenue | 674.43 Thousand | 640.24 Thousand | 853.52 Thousand | 2.28 Million | 691.67 Thousand | 318.57 Thousand |
| Gross Profit | 370.77 Thousand | 484.06 Thousand | 500.87 Thousand | 1.2 Million | 261.77 Thousand | 229.47 Thousand |
| Operating Expenses | 5.00 | 319.32 Thousand | 435.58 Thousand | 1.89 Million | 544.34 Thousand | 511.85 Thousand |
| Selling, General and Administrative Expenses | 304.37 Thousand | 319.32 Thousand | 435.58 Thousand | - | 479.33 Thousand | 500.94 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 5.00 | - | - | - | - | - |
| Cost and Expenses | 674.43 Thousand | 959.57 Thousand | 1.28 Million | 4.17 Million | 1.23 Million | 830.43 Thousand |
| Operating Income | 370.78 Thousand | 164.74 Thousand | 65.29 Thousand | -691.84 Thousand | -281.99 Thousand | -282.18 Thousand |
| Interest Expense | - | 6256.00 | - | - | 1930.00 | 1757.00 |
| Income Tax Expense | -54.02 Thousand | 1.00 | 3.00 | 3.00 | 2492.00 | 1841.00 |
| Earnings before Tax | 54.02 Thousand | 168.53 Thousand | 59.58 Thousand | -701.21 Thousand | -285.06 Thousand | -284.22 Thousand |
| Net Income | 54.02 Thousand | 168.53 Thousand | 59.58 Thousand | -701.21 Thousand | -285.06 Thousand | -284.22 Thousand |
| Earnings Per Share Basic | 0.00 | 0.00 | 0.00 | - | -0.00 | -0.00 |
| Earnings Per Share Diluted | 0.00 | 0.00 | 0.00 | - | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 99.87 Million | 99.74 Million | 99.64 Million | 99.55 Million | 99.64 Million | 99.62 Million |
| Weighted Average Shares Outstanding (Diluted) | 105.61 Million | 99.74 Million | 99.64 Million | 99.55 Million | 99.64 Million | 99.62 Million |
| Gross Margin | 0.35 | 0.43 | 0.37 | 0.34 | 0.27 | 0.42 |
| EBIT Margin | 0.41 | 0.24 | 0.15 | - | -0.17 | -0.51 |
| Profit Margin | 0.05 | 0.15 | 0.04 | -0.20 | -0.30 | -0.52 |
| EBITDA | 424.8 Thousand | 274.34 Thousand | 197.77 Thousand | - | -161.58 Thousand | -281.4 Thousand |
| Earnings Before Tax Margin | 0.35 | 0.15 | 0.05 | -0.20 | -0.30 | -0.51 |
PSYBF
DVYSR
1798
FCNCB
NCLIND
ALTX